MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202611069619 A) filed by Chitkara University on June 03, 2026, for Novel Chalcone-Triazole Propenone Compound As Cxxc5 Protein Inhibitor For Management Of Diabetes Mellitus.
Inventors include Dr. Mandeep Kaur; and Dr. Sushma.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: ABSTRACT NOVEL CHALCONE-TRIAZOLE PROPENONE COMPOUND AS CXXC5 PROTEIN INHIBITOR FOR MANAGEMENT OF DIABETES MELLITUS The present invention relates to a novel chalcone-triazole propenone compound of Formula (I), or pharmaceutically acceptable salts thereof, for use as a CXXC5 protein inhibitor for the management and treatment of Type 2 Diabetes Mellitus (T2DM). Compound I
Disclaimer: Curated by HT Syndication.
